Envestnet Asset Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,137
| Closed | -$10.2K | – | 4126 |
|
|
2023
Q3 | $10.2K | Sell |
1,137
-3,090
| -73% | -$27.6K | ﹤0.01% | 3995 |
|
|
2023
Q2 | $36.5K | Buy |
+4,227
| New | +$36.5K | ﹤0.01% | 3898 |
|
|
2022
Q1 | – | Sell |
-954
| Closed | -$193K | – | 4016 |
|
|
2021
Q4 | $193K | Sell |
954
-17
| -2% | -$3.44K | ﹤0.01% | 3668 |
|
|
2021
Q3 | $262K | Buy |
971
+67
| +7% | +$18.1K | ﹤0.01% | 3364 |
|
|
2021
Q2 | $233K | Sell |
904
-210
| -19% | -$54.1K | ﹤0.01% | 3426 |
|
|
2021
Q1 | $334K | Buy |
1,114
+313
| +39% | +$93.8K | ﹤0.01% | 3079 |
|
|
2020
Q4 | $204K | Buy |
+801
| New | +$204K | ﹤0.01% | 3131 |
|
|
2019
Q3 | – | Sell |
-458
| Closed | -$244K | – | 3139 |
|
|
2019
Q2 | $244K | Sell |
458
-31
| -6% | -$16.5K | ﹤0.01% | 2796 |
|
|
2019
Q1 | $246K | Sell |
489
-27
| -5% | -$13.6K | ﹤0.01% | 2728 |
|
|
2018
Q4 | $254K | Sell |
516
-3,826
| -88% | -$1.88M | ﹤0.01% | 2527 |
|
|
2018
Q3 | $3.97M | Buy |
4,342
+4,276
| +6,479% | +$3.91M | 0.01% | 470 |
|
|
2018
Q2 | $47K | Sell |
66
-6
| -8% | -$4.27K | ﹤0.01% | 2226 |
|
|
2018
Q1 | $109K | Buy |
72
+15
| +26% | +$22.7K | ﹤0.01% | 1879 |
|
|
2017
Q4 | $51K | Buy |
+57
| New | +$51K | ﹤0.01% | 2312 |
|
|
2017
Q1 | – | Sell |
-5
| Closed | -$1K | – | 3148 |
|
|
2016
Q4 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 3043 |
|